Clinical Trial Update: The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the effect of aspirin on reducing inflammation in an in vivo model of acute lung injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Belfast Health and Social Care Trust | Conditions: Acute Lung Injury | Phase 2 | Status: COMPLETED